CD4 and COVID-19: When the two megapools were combined to assess the overall CD4+ T cell reactivity OTD-CoV-2pos subjects showed a significantly higher reactivity when compared to both OTD-CoV-2neg or severe COVID-19 patients (Figure 1F).